42 CFR Part 2 Compliance in Behavioral Health: 8 Operational Controls Leaders Should Validate Now

The 2024 Part 2 Final Rule became effective April 16, 2024, and compliance with applicable requirements was required by February 16, 2026. The rule brought several aspects of Part 2 into closer alignment with HIPAA while maintaining important protections specific to substance use disorder records. 

For organizations that spent 2024 and 2025 preparing for the compliance date, the leadership questions should now be more operational: 

• Are approved policies reflected in actual workflows?  
• Are staff using current notices and consent forms?  
• Does the EHR behave the way written procedures say it should?  
• Do employees understand how to respond to common disclosure situations?  
• Have third-party and vendor workflows been evaluated?  
• Do incident-response procedures account for Part 2?  
• Can leadership demonstrate that these controls are being monitored?  
• An updated policy is important, but it is not proof that implementation succeeded. 

A stronger compliance model connects the requirement to the policy, the policy to the workflow, the workflow to technology and staff behavior, and those elements to evidence leadership can review. 

For behavioral health organizations, that evidence is what turns regulatory preparation into operational assurance. 

Operational testing should begin with scope. 

Part 2 is not synonymous with behavioral health privacy, and a behavioral health record does not become a Part 2 record simply because substance use is mentioned somewhere in the clinical record. 

HHS describes Part 2 protections in connection with certain records created or received by federally assisted programs or activities involving substance use disorder education, prevention, training, treatment, rehabilitation, or research. 

How the regulation applies to a particular organization, program, record, or circumstance may require organization-specific regulatory or legal analysis. 

Leadership should therefore be able to answer several foundational questions: 

• Which programs within the organization are potentially subject to Part 2?  
• Which workflows involve Part 2 records?  
• Which employees routinely handle those records?  
• Which information systems, interfaces, and portals are involved?  
• Which outside organizations receive or process the information?  
• Where does the organization obtain legal or regulatory guidance when applicability is uncertain?  

If scope is misunderstood, every control that follows can be designed incorrectly. 

Another important distinction involves record segmentation. The updated rule does not require organizations to segregate or technologically segment Part 2 records. Organizations may choose technical or workflow controls that support their operational needs, but those decisions should not be described as a universal federal segmentation requirement. 

From a leadership perspective, the objective is not to impose unnecessary complexity. It is to understand where Part 2 applies well enough to build appropriate controls around the records and workflows that are actually affected. 

Part 2 programs are required to provide patients with notice addressing applicable confidentiality requirements and patient rights. Part 2 programs that are also HIPAA covered entities may use a combined notice that satisfies both HIPAA and Part 2 requirements. 

Leadership should validate more than whether an approved notice exists. Review whether: 

• the current notice is being used consistently;  
• obsolete versions have been removed from circulation;  
• electronic and paper versions are aligned;  
• website or portal notices are current where applicable;  
• distribution procedures match organizational policy;  
• staff know when and how the notice must be provided; and  
• documentation practices reflect the approved workflow.  

A common implementation gap is version inconsistency. Compliance may approve a new notice while an older version remains embedded in an intake packet, patient portal, shared folder, or clinic workflow. That is not primarily a policy problem. It is an operational-control problem. 

The updated Part 2 framework also changed important aspects of consent. 

The Final Rule permits a single consent for future uses and disclosures for treatment, payment, and health care operations under applicable circumstances. It also maintains more specific protections for certain situations, including requirements involving SUD counseling notes and particular legal proceedings.

That comparison is important because the written policy may be correct while the electronic form, intake instructions, or release process still reflects an older standard. 

A strong validation process looks for consistency across all five points rather than assuming that updating one document updated the workflow. 

Disclosure decisions are where regulatory interpretation becomes operational behavior. 

Rather than limiting review to policy language, leadership should consider testing realistic scenarios staff encounter in daily operations. 

Examples may include: 

• treatment coordination;  
• payer-related requests;  
• release to another provider;  
• patient-directed disclosures;  
• public-health situations;  
• subpoenas and other legal requests;  
• disclosures involving business associates; and  
• requests involving SUD counseling notes.  

The updated framework is particularly important when evaluating redisclosure. 

Under applicable conditions, HIPAA covered entities and business associates receiving Part 2 records through the permitted treatment, payment, and health care operations consent framework may redisclose those records in accordance with HIPAA.

Part 2, however, continues to maintain additional protections, including significant restrictions involving the use of Part 2 records in proceedings against patients without the necessary consent or court authorization. 

Organizations should therefore avoid relying on an outdated generalized rule that Part 2 information can simply “never be redisclosed.” 

The better question is: Does our current workflow produce the correct decision for the specific disclosure being requested? 

Scenario testing can uncover problems that policy review alone may miss. 

If several staff members receive the same hypothetical request and arrive at different answers, leadership has learned something important. The organization may have: 

• unclear policy language;  
• insufficient training;  
• inconsistent escalation practices;  
• poorly designed workflows; or  
• uncertainty about regulatory interpretation.  

Whatever the cause, inconsistent decision-making is a signal that the control deserves closer review.

Written policies cannot compensate for technology or information-handling processes that operate differently from those policies. 

That does not mean Part 2 requires one specific technical architecture. It does not. 

The operational question is whether the organization's systems and workflows support the requirements that actually apply. 

Leadership should evaluate areas such as: 

• role-based access appropriate to organizational policy and applicable requirements;  
• how Part 2-related information moves through the EHR;  
• release-of-information workflows;  
• interoperability interfaces;  
• patient portals;  
• document queues;  
• scanning and indexing practices;  
• health information exchange workflows;  
• downstream vendor handling;  
• business associate and qualified service organization relationships, where applicable; and  
• whether system configurations match current consent and disclosure procedures.  

This is one area where compliance, privacy, health information management, operations, and IT should not work independently. 

For example, a policy may require a particular review before information is released. If the actual EHR workflow allows that step to be bypassed, the written policy and the operating environment are no longer aligned. 

The same issue can occur downstream. 

Leadership should understand where relevant information travels outside the organization, who receives it, what contractual or regulatory relationship applies, and who is responsible for each stage of the workflow. 

The objective is not to add technology controls simply because Part 2 is involved. It is to verify that applicable Part 2 requirements, HIPAA privacy and security requirements, organizational policies, and actual information-handling practices work together.

Implementation is not complete because employees attended training. 

The stronger measure is whether staff can apply the organization's requirements correctly when faced with situations they actually encounter. 

Organizations should evaluate whether Part 2 training is: 

• current;  
• appropriate to employees' responsibilities;  
• incorporated into onboarding where needed;  
• reinforced periodically;  
• supported by clear escalation procedures; and  
• tested through realistic scenarios rather than awareness alone.  

Role-specificity matters. 

An intake employee, clinician, billing professional, HIM employee, privacy officer, and IT administrator may interact with Part 2 information in very different ways. Giving each employee the same broad overview may satisfy an internal training schedule without necessarily preparing them to perform their responsibilities correctly. 

Effective training should help employees understand what to do, when to escalate, and where to obtain guidance when the answer is unclear.

Incident-response procedures also warrant review. 

The updated Part 2 rule applies HIPAA Breach Notification Rule requirements to breaches involving Part 2 records. Part 2 programs may therefore have notification and reporting responsibilities involving affected individuals, HHS, and, in some circumstances, the media. 

Leadership should verify that privacy and security incident processes actually account for Part 2 information when applicable. 

Questions to examine include: 

• Can staff recognize and escalate a potential Part 2 incident?  
• Does the assessment process identify whether Part 2 records are involved?  
• Are responsibility and decision-making authority clearly assigned?  
• Do investigation and notification procedures reflect current requirements?  
• Are corrective actions documented and completed?  

Sustainable ongoing behavioral health compliance also requires a way to determine whether controls continue to operate after implementation. 

Depending on the organization's operations and risks, monitoring may include: 

• disclosure reviews;  
• workflow audits;  
• training completion and competency checks;  
• privacy investigations;  
• incident trends;  
• corrective action plans;  
• repeat findings; and  
• governance reporting.  

These are operational compliance practices, not a claim that Part 2 requires one universal monitoring schedule for every organization. 

The purpose is to create evidence. 

From a consulting perspective, this is where leadership teams often discover the difference between having a compliance program and being able to demonstrate that the program is functioning. 

If the only evidence that a control works is that the policy says it should, leadership still has an unanswered question. 

This type of monitoring also helps leadership identify broader compliance risks leadership should monitor rather than evaluating Part 2 in isolation. 

Leadership should not evaluate these controls solely by asking whether each one exists. 

The stronger question is: What evidence demonstrates that the control is functioning as intended? 

The following framework connects eight operational control areas with the leadership question to ask, the evidence to review, and a warning sign that may indicate further evaluation is needed.

An organization may discover an outdated form, a training issue, or a single workflow that can be corrected internally. 

A broader review may become appropriate when the uncertainty crosses several operational areas or when leadership cannot confidently determine whether the organization's controls are functioning as intended. 

Warning signs may include: 

• Part 2 applicability has never been formally evaluated;  
• policies were updated but workflows were not tested;  
• outdated consent or notice forms remain in use;  
• EHR processes do not clearly correspond to written procedures;  
• staff provide inconsistent answers to common disclosure scenarios;  
• vendor or data-flow responsibilities are unclear;  
• Part 2 considerations are missing from privacy incident procedures;  
• there is little evidence of ongoing compliance monitoring; or  
• leadership cannot demonstrate how identified gaps are tracked and corrected. 

At that point, the issue is broader than a single policy or document. 

A healthcare compliance assessment can help leadership examine whether governance, policies, workflows, technology, workforce practices, monitoring, and corrective action are aligned. 

For organizations managing both HIPAA-regulated information and records subject to Part 2, that review can also help identify where the two frameworks intersect operationally and where additional legal or regulatory guidance may be appropriate.